Cargando…
SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: retrospective evaluation of nosocomial infection control
Autores principales: | Hibino, M., Iwabuchi, S., Munakata, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544697/ https://www.ncbi.nlm.nih.gov/pubmed/33039454 http://dx.doi.org/10.1016/j.jhin.2020.10.001 |
Ejemplares similares
-
Assessing the Pre-Vaccination Anti-SARS-CoV-2 IgG Seroprevalence among Residents and Staff in Nursing Home in Niigata, Japan, November 2020
por: Wagatsuma, Keita, et al.
Publicado: (2022) -
Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021) -
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021) -
Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States
por: Lopez, Lilah, et al.
Publicado: (2020) -
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States
por: Lopez, Lilah, et al.
Publicado: (2021)